Status:
UNKNOWN
Customized Choice of Oral P2Y12 Receptor Blocker
Lead Sponsor:
Italian Society of Invasive Cardiology
Collaborating Sponsors:
Eustrategy
Conditions:
Acute Coronary Syndrome
Coronary Angioplasty
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
A subset of patients recruited in the main MATRIX study will be randomized after intervention but before discharge to standard of care (the treating physician will decide which oral P2Y12 inhibitor wi...
Detailed Description
Up to 20-30% of clopidogrel treated patients do not adequately respond to the drug and are at higher risk for ischemic events including death, myocardial infarction, stroke and stent thrombosis. Resi...
Eligibility Criteria
Inclusion
- patients recruited in the main MATRIX study who underwent coronary angioplasty with stent placement.
Exclusion
- unwillingness to sign this sub study specific informed consent
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT01477775
Start Date
January 1 2012
End Date
December 1 2015
Last Update
September 3 2014
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera Pugliese Ciaccio
Catanzaro, Calabria, Italy, 88100
2
University Hospital of Ferrara
Ferrara, Ferrara, Italy, 44100
3
Azienda Ospedaliera Fatebenefratelli e Oftalmico
Milan, MI, Italy, 20121
4
Spedali Civili di Brescia
Brescia, Italy